Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert O. Dillman, MD, FACP
Cancer Biotherapy Research Group
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- Bloomington Hospital
Bloomington, Indiana, United States
- St. Vincent Hospital and Health Care Center Research Department
Indianapolis, Indiana, United States
- Bergan Mercy Medical Center
Omaha, Nebraska, United States
- Baptist Regional Cancer Center - Knoxville
Knoxville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 1992
- Primary completion
- 28 Feb 1998
- Completion
- 28 Feb 1999
- Last update posted
- 12 May 2011
- Registered enrollment
- —
- Registry id
- NCT00002504
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.